RNA melanoma vaccine: Induction of antitumor immunity by human glycoprotein 100 mRNA immunization

Human Gene Therapy

Volumn 10, Issue 16, 1999, Pages 2719-2724

  Zhou, W Z ^a   Hoon, D S B ^b   Huang, S K S ^b   Fujii, S ^b   Hashimoto, K ^b   Morishita, R ^a   Kaneda, Y ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CANCER VACCINE; GLYCOPROTEIN; LIPOSOME; MELANOMA ANTIGEN; MESSENGER RNA; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CANCER PREVENTION; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MALE; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN;

ANIMALS; CANCER VACCINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; GENE TRANSFER TECHNIQUES; HUMANS; INJECTIONS; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; RNA, MESSENGER; SPLEEN; SURVIVAL RATE; VACCINES, SYNTHETIC;

ANIMALIA;

EID: 0033231048     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016762     Document Type: Article

References (19)

1. ASHLEY, D.M., FAIOLA, B., NAIR, S., HALE, L.P., BIGNER, D.D., and GILBOA, E. (1997). Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 186, 1177-1182.
2. BERGLUND, P., SMERDOU, C., FLEETON, M.N., TUBULEKAS, I., and LILJESTROM, P. (1998). Enhancing immune responses using suicidal DNA vaccines. Nature Biotechnol. 16, 562-565.
3. CHEN, Y., HU, D., ELING, D.J., ROBBINS, J., and KIPPS, T.J. (1998). DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res. 58, 1965-1971.
4. FUJIWARA, H., YOSHIOKA, T., SHIMA, J., KOSUGI, A., ITOH, K., and HAMAOKA, T. (1986). Helper T cells against tumor-associated antigens (TAA): Preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses. J. Immunol. 136, 2715-2719.
5. HIRANO, T., FUJIMOTO, J., UEKI, T., YAMAMOTO, H., IWASAKI, T., MORISHITA, R., SAWA, Y., KANEDA, Y., TAKAHASHI, H., and OKAMOTO, E. (1998). Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome. Gene Ther. 5, 459-464.
6. HO, T.Y., HSIANG, C.-Y., HSIANG, C.-H., and CHNAG, T.-J. (1998). DNA vaccination induces a long-term antibody response and protective immunity against pseudorabies virus in mice. Arch. Virol. 143, 115-125.
7. HUANG, S.K.S., OKAMOTO, T., MORTON, D.L., and HOON, D.S.B. (1998). Antibody responses to melanoma/melanocyte anto-antigens in melanoma patients. J. Invest. Dermatol. 111, 662-667.
8. IWASAKI, A., and BARBER, B.H. (1998). Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor. Cancer Immunol. Immunother. 45, 273-279.
9. KANEDA, Y., IWAI, K., and UCHIDA, T. (1989). Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243, 375-378.
10. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., SAKAGUCHI, K., APPELLA, E., YANNELLI, J.R., ADEMA, G.J., MIKI, T., and ROSENBERG, S.A. (1994). Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. U.S.A. 91, 6458-6462.
11. LARSEN, D.L., DIBDAHL-SISSOCO, N., McGREGOR, M.W., DRAPE, R., NEUMANN, V., SWAIN, W.F., LUNN, D.P., and OLSEN, C.W. (1998). Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. J. Virol. 72, 1704-1708.
12. LILJESTROM, P., and GAROFF, H. (1991). A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 9, 1356-1361.
13. MANDL, C.H., ABERLE, J.H., ABERLE, S.W., HOLZMANN, H., ALLISON, S., and HEINZ, F.X. (1998). In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nature Med. 4, 1438-1440.
14. MARTINON, F., KRISHNAN, S., MAGNE, R., GOMARD, E., GUILLET, J.-G., LEVY, J.-P., and MEULIEN, P. (1993). Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. Immunol. 23, 1719-1722.
15. MORISHITA, R., GIBBONS, G.H., ELLISON, K.E., NAKAJIMA, M., ZHANG, L., KANEDA, Y., OGIHARA, T., and DZAU, V.J. (1993). Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal by perplasia. Proc. Natl. Acad. Sci. U.S.A. 90, 8474-8478.
16. NESTLE, F.O., ALIJAGIC, S., GILLIET, M., SUN, Y., GRABBE, S., DUMMER, R., BURG, G., and SCHADENDORF, D. (1998). Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med. 4, 328-332.
17. OKAMOTO, T., KANEDA, Y., YUZUKI, D., HUANG, S.K.S., CHI, D.D.J., and HOON, D.S.B. (1997). Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine. Gene Ther. 4, 969-976.
18. SAEKI, Y., MATSUMOTO, N., NAKANO, Y., MORI, M., AWAI, K., and KANEDA, Y. (1997). Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): Reciprocal effect of cationic lipid for in vivo and in vitro gene transfer. Hum. Gene Ther. 8, 2133-2141.
19. ZHAI, Y., YANG, J.C., KAWAKAMI, Y., SPIESS, P., WADSWORTH, S.C., CARDOZA, L.M., COUTURE, L.A., SMITH, A.E., and ROSENBERG, S.A. (1996). Antigen-specific tumor vaccines: Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J. Immunol. 156, 700-710.